Kliogest (Norethisterone Acetate, Estradiol)

Norethisterone acetate is a synthetic progestogen that binds to progesterone receptors, suppressing luteinizing hormone (LH) and follicle‑stimulating hormone (FSH) release and preventing ovulation. Estradiol provides estrogenic activity, stabilising the endometrium and contributing to negative feedback on the hypothalamic‑pituitary axis, together creating an environment that prevents pregnancy.

The dosing regimen for Kliogest is determined by the prescribing clinician based on individual patient factors and local guidelines. Typically, it is taken once daily for a defined cycle, but the exact tablet strength, number of tablets per cycle, and duration must be prescribed by a qualified healthcare provider.

Kliogest is contraindicated during pregnancy because it is intended to prevent conception. If pregnancy occurs, the medication should be discontinued. Limited data are available for breastfeeding; therefore, a healthcare professional should evaluate the risk‑benefit ratio before use in lactating women.

To request Kliogest, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Kliogest contains norethisterone acetate and estradiol, whereas many other combined oral contraceptives use ethinyl estradiol as the estrogen component. Estradiol is a natural estrogen, which may offer a different side‑effect profile, but efficacy in preventing pregnancy is comparable when taken as directed. Choice depends on individual tolerance and physician recommendation.

Kliogest tablets should be stored at ambient temperature, preferably below 25 °C, in the original packaging to protect them from moisture and light. Keep the medication out of reach of children and do not use if the package is damaged.

Kliogest is taken orally, usually once daily at the same time each day, with or without food, as directed by the prescriber. The tablet should be swallowed whole with water and not chewed or split unless specifically instructed.

The most serious risks include thromboembolic events such as deep vein thrombosis, pulmonary embolism, stroke, and myocardial infarction, especially in women with pre‑existing risk factors. Rare cases of severe allergic reactions and liver dysfunction have also been reported. Prompt medical attention is required if symptoms of these conditions appear.

Kliogest should not be used by women who are pregnant, have a history of thromboembolic disorders, uncontrolled hypertension, active liver disease, known or suspected breast cancer, or who are smokers over 35 years of age. It is also contraindicated in individuals with known hypersensitivity to any of its components.